• Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021

    8 days ago - By San Diego Biotechnology

    SAN DIEGO and TORONTO, July 20, 2021 - Aptose Biosciences Inc. , a clinical stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will report financial results for the quarter ended June 30, 2021, and provide a corporate update on Tuesday,...
    Read more ...

     

  • Sorrento Therapeutics Announces the Formation of Sorrento Therapeutics Mexico for Commercialization of COVI-STIX and Development of Sorrento's Portfolio of COVID-19 Products in Mexico and Parts of Latin America

    8 days ago - By San Diego Biotechnology

    SAN DIEGO, July 20, 2021 - Sorrento Therapeutics, Inc. today announced that it has formed a subsidiary company based in Mexico City, Sorrento Therapeutics Mexico , to support the clinical development and registration of multiple COVID-19 related products Sorrento plans to develop and...
    Read more ...